Literature DB >> 8572632

Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma.

T Mazzei1, F Tonelli, E Mini, P Mazzoni, A Pesciullesi, R Valanzano, F Ficari, C Biondi, P Periti.   

Abstract

The aim of this study was to evaluate the relationship between DNA ploidy, proliferative activity and other prognostic factors and the survival of patients with colorectal cancer. 45 patients were prospectively investigated for 6 years. Fresh multiple samples for flow cytometric analysis of DNA content were collected during surgical resection of primary tumor. A 42% frequency of aneuploidy was observed with a median DNA index value of 1.54. The proliferative activity (%S+G2M cells) was higher in the aneuploid cell sub-population (28.6%) compared to the diploid counterpart (22.7%)(p = 0.05). No significant relationship between DNA ploidy and tumor site, Dukes' stage, histological type, grading age or sex was observed. No correlation between DNA ploidy and survival was demonstrated, including in the analysis of patient subsets according to stage. No additive prognostic information was obtained from a breakdown analysis as a function of DI values, percentages of aneuploid cells and proliferative activity. This study suggests that flow cytometric content analysis lacks prognostic value in colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8572632

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results.

Authors:  M Minagawa; M Makuuchi; G Torzilli; T Takayama; S Kawasaki; T Kosuge; J Yamamoto; H Imamura
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

2.  Automated imaging cytometry reveals dysplastic indices of colonic serrated adenomas.

Authors:  Nicholas S Samel; Qin Huang; Hiroshi Mashimo
Journal:  Future Sci OA       Date:  2020-02-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.